~ Scand J Gastroenterol
published a landmark study in Nature Communications showing that MOTS-c treatment could double treadmill running capacity in old mice, restoring physical performance to levels seen in animals a fraction of their age.2 Meanwhile, orthopedic surgeons were cataloguing a parallel revolution: synthetic peptides like BPC-157, originally derived from a protective protein in human gastric juice, were showing preclinical promise in accelerating tendon, ligament, and muscle repairthe very tissues endurance athletes stress on an almost daily basis.3 The peptide therapeutics market is no longer a niche curiosity
Carbohydrate-elevated insulin states blunt GH pulse
Clinical Evidence Gap The legal restrictions track the reality that most evidence is preclinical
In this honest review, we break down what the product does, how to use it, and who its best suited for
Additional studies on silymarin and its possible impact on the health of the urinary tract, especially cystitis, will therefore be useful in the effort to establish the other uses of the substance apart from conditions affecting the liver